In our previous studies employing adenoviral vectors encoding human VASH1 (hVASH1) in the murine type 1 and type 2 diabetes models, we observed therapeutic effects on diabetic renal alterations [25], [26]. This evidence concerns the gene VASH1 and type 2 diabetes mellitus.